Potencort 0.05% Cream
Fluticasone Propionate 0.05% Topical
0.5mg/g
Julphar (Gulf Pharmaceutical Industries)
| Pack size | 15g Tube |
|---|---|
| Dispensing mode | POM |
| Source | UAE |
| Agent | JULPHAR |
| Retail Price | 13.00 AED |
Indications
Potencort 0.05% Cream is used for:
Psoriasis, Eczema, Corticosteroid-responsive dermatoses
Adult Dose
Topical cream
Atopic Dermatitis, Corticosteroid-responsive Dermatoses
Apply a thin film to the affected skin areas once or twice daily.
Rub in gently. Reassess diagnosis if no improvements within 2 weeks
Child Dose
Topical cream
Atopic Dermatitis, Corticosteroid-responsive Dermatoses
Child > 3 months: Apply a thin film to the affected skin areas once or twice daily.
Renal Dose
Administration
Contra Indications
Hypersensitivity. Acne vulgaris, rosacea, perioral dermatitis, skin atrophy; hypersensitivity. Primary cutaneous viral infections (e.g. herpes simplex, chicken pox), perianal and genital pruritus, primary fungal or bacterial skin infections. Inhalation: Status asthmaticus.
Precautions
Children, pregnancy, lactation, concomitant skin infections. Concomitant skin/lung/systemic infections. Advised to rinse mouth with water every time after inhalation. Application to large areas, broken skin or under occlusive dressings.
Lactation: Excretion in milk unknown; use with caution
Pregnancy-Lactation
Pregnancy Category: C
Lactation: Excretion in milk unknown; use with caution
Interactions
May lead to increased plasma concentrations of fluticasone when used with CYP4503A4 inhibitors such as ritonavir.
Adverse Effects
Side effects of Fluticasone Propionate 0.05% Topical :
1-10%
Pruritus (2.9%), Dryness (1.2%), Skin irritation: (3%), Eczema (1%), Telangiectasia (2-5%), Numbness of fingers (1%)
<1%
Burning, Folliculitis, Acneiform lesions, Urticaria, Hypertrichosis, Lightheadedness, Viral, Warts, Impetigo, Skin infection
Frequency Not Defined
Striae, Pigmentation changes, HPA suppression (with higher potency used >2 wk), Erythema, Cushing syndrome, Sepsis, Hemorrhage reported, Edema/swelling
Potentially Fatal: Suppression of immune system.
Mechanism of Action
Fluticasone utilises a fluorocarbothioate ester linkage at the C17 position. It has potent vasoconstrictive and anti-inflammatory activity, but weak HPA inhibitory effect when applied topically.
Note
Potencort 0.05% 0.5mg/g Cream manufactured by Julphar (Gulf Pharmaceutical Industries). Its generic name is Fluticasone Propionate 0.05% Topical. Potencort 0.05% is availble in United Arab Emirates.
Farmaco UAE drug index information on Potencort 0.05% Cream is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.